Successful Semi Annual Meeting of RePORT-Brazil
October 31, 2022
The Regional Prospective Observational Research for Tuberculosis (RePORT) - Brazil Semi Annual Meeting was held October 17th through October 21st in Salvador, Bahia. Investigators and staff from throughout the network participated in a variety of workshops, presentations, and collaborative planning sessions, both in-person and from remote locations.
VUMC lands Grant to build top-line Biosafety Facility
October 3, 2022
https://news.vumc.org/2022/09/29/vumc-lands-grant-to-build-top-line-biosafety-facility/
Vanderbilt University Medical Center has been awarded a nearly $8 million grant from the National Institutes of Health to construct a state-of-the-art BioSafety Level 3 (BSL3) facility for research involving the COVID-19 virus, anthrax and other dangerous microorganisms. When the renovation of about 3,500 square feet of existing space is completed, the facility will include three BSL3 suites with separate entrances and seven procedure rooms capable of securely containing multiple organisms at the second-highest biosafety level.
VUMC investigators attend RePORT-International Annual Meeting
September 15, 2022
VUMC investigators and staff, Timothy Sterling, Yuri van der Heijden, Stephany Duda, Marina Figueiredo, Fernanda Mauri, Megan Turner, and Austin Katona; attended the annual RePORT International meeting that was held in Cape Town, South Africa, September 7 and 8, 2022. The meeting included all seven regions of RePORT: Brazil, China, South Africa, South Korea, India, Indonesia, and the Philippines. It was a successful meeting full of presentations and collaborative discussions.
Leonardo Barreto's work in the Sterling Lab investigating MIC in Mtb isolates
August 31, 2022
Leonardo Barreto, Public Health Technologist at Instituto Nacional de Infectologia Evandro Chagas – FIOCRUZ, has spent the last 6 months in the Sterling Lab evaluating subtle changes in drug resistance (Minimum Inhibitory Concentration - MIC) in M. tuberculosis isolates from study participants from the NIH-funded project “Predictors of treatment toxicity, failure, and relapse in HIV-related tuberculosis” (R01AI120790).
Welcome Kelly Dooley, MD, PhD, MPH as the new Director of the Division of Infectious Diseases!
June 30, 2022
The Vanderbilt TB Center is excited to welcome Kelly Dooley to VUMC!
Kelly Dooley, MD, PhD, MPH, has been appointed Addison B. Scoville Jr. Professor of Medicine and director of the Division of Infectious Diseases in the Department of Medicine at Vanderbilt University Medical Center, effective Sept. 12.
Nancy Séraphin, MPH, PhD visits Vanderbilt TB Center
June 28, 2022
Nancy Séraphin, MPH, PhD, Research Assistant Professor in the Department of Medicine, Division of Infectious Diseases and Global Medicine (IDGM), and the Emerging Pathogens Institute (EPI) at the University of Florida visited VUMC between June 13th-15th. Her visit was highlighted by meetings with the TB Center team, collaborative discussions with researchers at VUMC, and the presentation of a guest lecture entitled: "The public health importance of Mycobacterium tuberculosis intra-host genetic variability”.
Vanderbilt TB Center wins Joe B. Ware Partner Service Award
June 20, 2022
During the 2022 Annual Conference of the National Tuberculosis Controllers Association, The Vanderbilt TB Center was awarded the Joe B. Ware Partner Service Award.
The award “recognizes an organization that has made a significant effort and/or contribution to the mission of TB control and prevention through partnership activities with public health TB programs.”
VTC hosts visitors from Brazil, South Africa, UW for grant project meeting
June 14, 2022
Vanderbilt Tuberculosis Center recently hosted a meeting of researchers involved in our LTBI R01 project “Immunogenetic predictors of active and incipient TB in HIV-negative and -positive close TB contacts” (NIH R01AI147765). The event, which took place between May 31st and June 2nd, included presentations about ongoing research and initial data, working group sessions, and breakout meetings.
WHO Global TB Report was released!
October 28, 2021
Each year, the WHO Global TB Report provides a comprehensive and up-to-date assessment of the TB epidemic, and of progress in prevention, diagnosis and treatment of the disease, at global, regional and country levels. This is done in the context of global TB commitments, strategies and targets.
New RePORT-Brazil publication: The Effect of Diabetes and Prediabetes on Anti-tuberculosis Treatment Outcomes: A Multi-center Prospective Cohort Study!
October 27, 2021
The Effect of Diabetes and Prediabetes on Anti-tuberculosis Treatment Outcomes: A Multi-center Prospective Cohort Study was generated from the RePORT-Brazil collaboration, led by Maria Arriaga, and published in The Journal of Infectious Diseases
Background: It is unclear whether diabetes or prediabetes affect unfavorable treatment outcomes and death in people with tuberculosis (PWTB).